Phase II — Trials
Phase II — Treatment of the following tumors in the liver with Melphalan: hepatocellular carcinoma (primary liver cancer), metastatic adenocarcinomas and neuroendocrine tumors in the liver and metastatic ocular and cutaneous melanoma that received prior regional Melphalan therapy; taking place at the National Cancer Institute
Phase III — Treatment of Metastatic Melanoma
Phase III— Treatment of Metastatic Melanoma in the Liver (Ocular and Cutaneous) with Melphalan, which took place at the National Cancer Institute, University of Maryland Medical Center, Albany Medical Center, St. Luke’s Cancer Center of Bethlehem, Morristown Memorial Hospital, University of Texas Medical Branch, Moffitt Cancer Center, John Wayne Cancer Center, Providence Health Systems and Swedish medical Center.